↓ Skip to main content

Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts

Overview of attention for article published in Investigational New Drugs, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
1 patent

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
28 Mendeley
Title
Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts
Published in
Investigational New Drugs, May 2013
DOI 10.1007/s10637-013-9969-0
Pubmed ID
Authors

Ah Young Jun, Hyun-Jeong Kim, Kwang-Kyun Park, Kun Ho Son, Dong Hwa Lee, Mi-Hee Woo, Won-Yoon Chung

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 11%
Student > Bachelor 3 11%
Student > Postgraduate 3 11%
Student > Doctoral Student 2 7%
Other 2 7%
Other 5 18%
Unknown 10 36%
Readers by discipline Count As %
Medicine and Dentistry 8 29%
Agricultural and Biological Sciences 5 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Philosophy 1 4%
Earth and Planetary Sciences 1 4%
Other 3 11%
Unknown 8 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2017.
All research outputs
#7,523,962
of 22,961,203 outputs
Outputs from Investigational New Drugs
#326
of 1,173 outputs
Outputs of similar age
#66,114
of 195,505 outputs
Outputs of similar age from Investigational New Drugs
#5
of 11 outputs
Altmetric has tracked 22,961,203 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,173 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,505 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.